Electrochemical sensor for determining blood clotting, corresponding system for measuring blood clotting and method for determining blood clotting

• US 20030146113A1
• Filed: 12/06/2002
• Published: 08/07/2003
• Est. Priority Date: 02/21/2000
• Status: Abandoned Application

• Current Assignee: Roche Diagnostics Operations Incorporated (Roche Holding AG)
• Original Assignee: Roche Diagnostics Operations Incorporated (Roche Holding AG)
• Inventors: Kotzan, Holger, Nortmeyer, Christine, Unkrig, Volker, Horn, Carina, Marquant, Michael, Hindelang, Fritz
• Application Number:
  US10/204,524
• Publication Number:
  US 20030146113A1
• Time in Patent Office: Days
• US Class Current: 205/792
• CPC Class Codes: C12Q 1/005 involving specific analytes or enzymes including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence
• CPC Class Codes: G01N 2333/974 Thrombin
• CPC Class Codes: G01N 33/86 involving blood coagulating time or factors, or their receptors

Abstract

The invention concerns an electrochemical sensor based on dry chemistry for determining blood coagulation or individual coagulation factors which has at least two electrodes on an inert support as well as a dry reagent, characterized in that the reagent contains a protease substrate which is composed of a peptide residue that can be cleaved off by a thrombin and is bound to a phenylenediamine residue via an amide bond at its carboxyl end and

a system for measuring blood coagulation containing such a sensor and an amperometer,

a method for determining blood coagulation using the sensor according to the invention and a reagent for determining blood coagulation containing a thrombin substrate which is composed of a peptide residue that can be cleaved off by thrombin and is bound via its carboxyl end to a phenylenediamine residue by means of an amide linkage, characterized in that it also contains a dye-oxidoreductase such as glucose-dye-oxidoreductase.

Claims

1. Electrochemical sensor based on dry chemistry for determining blood coagulation or individual coagulation factors which has at least two electrodes on an inert support as well as a dry reagent, characterized in that the reagent contains a protease substrate which is composed of a peptide residue that can be cleaved off by a protease of the blood coagulation system and is bound to substituted anilines and in particular to a phenylenediamine residue via an amide bond at its carboxyl end.

2. Electrochemical sensor as claimed in claim 1, characterized in that it contains two electrodes which are composed of the same material.

3. Electrochemical sensor as claimed in claim 2, characterized in that the electrode material is palladium.

4. Electrochemical sensor as claimed in one of the claims 1 or 3, characterized in that the protease is thrombin and the protease substrate is a thrombin substrate.

5. Electrochemical sensor as claimed in claim 4, characterized in that the thrombin substrate is a compound of formula VI,

6. Electrochemical sensor as claimed in one of the claims 1-5, characterized in that the reagent also contains a dye-oxidoreductase which is able to catalyse the conversion of a quinone diamine into a phenylenediamine.

7. Electrochemical sensor as claimed in claim 6, characterized in that the dye-oxidoreductase is glucose-dye-oxidoreductase.

8. System for measuring blood coagulation containing an electrochemical sensor and an instrument for measuring current, characterized in that a sensor as claimed in one of the claims 1-7 is used as the sensor.

9. Method for determining blood coagulation by means of an electrochemical sensor, characterized in that a constant voltage is applied to a sensor as claimed in one of the claims 1-7, the blood sample to be examined is applied to the sensor in such a manner that the reagent and the electrodes are moistened and the current flowing between the electrodes is measured over time.

10. Method as claimed in claim 9, characterized in that it is used to measure the prothrombin time (PT), the activated partial prothrombin time (aPTT) or the activated clotting time (ACT).

11. Method as claimed in claim 9 or 10, characterized in that the determination of the blood clotting time is corrected for haematocrit influence by means of an impedance measurement.

15. Method for determining the blood coagulation by means of an electrochemical sensor, characterized in that a voltage that changes linearly is applied to a sensor as claimed in one of the claims 1-7, the blood sample to be examined is applied to the sensor in such a way that the reagent and the electrodes are moistened and the current flowing between the electrodes is measured over time.

16. Method as claimed in claim 15, characterized in that the determination of the blood clotting time is corrected for haematocrit influence by means of an impedance measurement.

12. Reagent for the determination of blood coagulation containing a protease substrate which is composed of a peptide residue that can be cleaved off by a protease of the blood coagulation system which is bound via its carboxyl end and an amide linkage to a phenylenediamine residue, characterized in that it contains a dye-oxidoreductase.

13. Reagent as claimed in claim 12, characterized in that the dye-oxidoreductase is glucose-dye-oxidoreductase.

14. Reagent as claimed in claim 12 or 13, characterized in that the protease is thrombin and the protease substrate is a thrombin substrate.